Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cross Country Healthcare, Inc. - Common Stock (NQ:CCRN)

12.10 -0.02 (-0.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cross Country Healthcare, Inc. - Common Stock

< Previous 1 2 3 Next >
CCRN Earnings Drop 19%
Via The Motley Fool
US Stocks Likely To Open Higher After Nasdaq 100 Enters Correction Zone: 'Economic Resilience Provides A Foundation For Market Stabilization,' Says Expert
U.S. stock futures rose on Friday following Thursday's selloff that pushed the Nasdaq 100 index into the correction zone. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Nasdaq Surges 150 Points; ISM Services PMI Falls In November
 
Via Benzinga
A Peek at Cross Country Healthcare's Future Earnings
 
Via Benzinga
4 Analysts Have This To Say About Cross Country Healthcare
 
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
Earnings Outlook For Cross Country Healthcare
 
Via Benzinga
Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Cross Country Healthcare Agrees To Be Acquired By Aya Healthcare, Shareholders To Receive 67% Premium
Cross Country Healthcare, Inc. shares are soaring premarket after agreeing to be acquired by Aya Healthcare for $18.61 per share in an all-cash deal valued at $615 million. The merger will expand Aya's... 
Via Benzinga
CCRN Stock Earnings: Cross Country Healthcare Misses EPS, Beats Revenue for Q2 2024
CCRN stock results show that Cross Country Healthcare missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
A Glimpse Into The Expert Outlook On Cross Country Healthcare Through 4 Analysts
 
Via Benzinga
CCRN Stock Earnings: Cross Country Healthcare Beats EPS, Beats Revenue for Q1 2024
CCRN stock results show that Cross Country Healthcare beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
The Latest Analyst Ratings for Cross Country Healthcare
 
Via Benzinga
Cross Country Healthcare's Earnings Outlook
 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
Analyst Expectations for Cross Country Healthcare's Future
 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
Credit Suisse Maintains Neutral Rating for Cross Country Healthcare: Here's What You Need To Know
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
7 Small-Cap Stocks Signaling a Sizeable Breakout
While the segment is risky, if you want to maximize your return potential, these small-cap breakout stocks should entice. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.